gynecological malignant tumor
Conditions
Interventions
ctDNA positive:non-intervention
ctDNA negative:non-intervention
Sponsors
The First People's Hospital of Foshan
Eligibility
Sex/Gender
Female
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Presence with cervical cancer, ovarian cancer and high-risk uterine malignant tumor confirmed by histopathology; (2) 18-75 years old; (3) The estimated survival time was more than 6 months; (4) General condition: ECOG 0-2; (5) Blood biochemical indexes were normal; (6) Be able to understand the research protocol and participate in the study voluntarily and sign the informed consent form; (7) Good compliance, can cooperate with the collection of specimens of each node, and provide the corresponding clinical information.
Exclusion criteria
Exclusion criteria: (1) Participants in other clinical trials within three months; (2) who had a history of other malignant tumors; (3) Pregnant or lactating women; (4) who with a history of serious mental illness; (5) Patients who could not understand the content of the experiment and could not cooperate with them and refused to sign the informed consent form; (6) who had received targeted therapy; (7) who with contraindications to surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| tumor recurrence; | — |
Countries
China
Contacts
Public ContactSonghua Yuan
The First People's Hospital of Foshan
Outcome results
None listed